ArticleOncotarget2017

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models.

Kristian W Pajtler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.